Trials / Unknown
UnknownNCT01670617
DeNovo NT Natural Tissue Graft Stratified Knee Study
A Stratified, Post-Market Study of DeNovo NT for the Treatment of Femoral and Patellar Articular Cartilage Lesions of the Knee
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Zimmer Orthobiologics, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the long-term relief of pain and return to function for patients receiving DeNovo NT for cartilage lesions in the knee. DeNovo NT is a marketed product and has been used in more than 7,500 patients over the last 7 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Particulated Juvenile Articular Cartilage | Treatment of articular cartilage defects up to 7.5 cm2 |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2018-12-01
- Completion
- 2021-12-01
- First posted
- 2012-08-22
- Last updated
- 2017-01-26
Locations
18 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT01670617. Inclusion in this directory is not an endorsement.